search
medical technology companies
Trends
- 1Precision Neuroscience raises $250 million for brain-computer interfaces▼Precision Neuroscience Raises $250 Million Series D To Advance Brain-Computer Interface Technology
Precision Neuroscience has raised $250 million in a Series D funding round to advance its brain-computer interface technology. The company, which develops implants designed to help people with neurological conditions, is part of a growing field of neurotech firms competing to bring brain-computer interfaces from the lab toward real-world medical use. The funding will support further development and commercialisation efforts.
- 2China's exoskeleton robots enter the consumer market▼China's exoskeleton robots muscle into the consumer mainstream
Chinese companies are bringing exoskeleton robots beyond industrial and medical settings and into the consumer mainstream. The wearable robotic devices, which assist with walking, lifting and mobility, are being marketed to ordinary users rather than factories or hospitals, a shift that signals China's ambitions to lead in consumer-facing robotics as global interest in the technology grows.
- 3Medtronic Expands Into Robotics and AI Healthcare●Why Is Medtronic (MDT) Expanding In Robotics And AI Healthcare?
Medtronic, the global medical device maker, is investing in robotics and artificial intelligence for healthcare, raising questions among investors about the strategy behind the expansion. The move points to the company's push to grow beyond traditional devices into surgical robotics and AI-driven care, sectors where competitors are also racing to establish a lead.
- 4IBA and Penn Medicine Launch Noventra Oncology Joint Venture●IBA, Penn Medicine Announce Noventra Oncology Alliance Joint Venture
IBA and Penn Medicine have announced the creation of Noventra Oncology Alliance, a joint venture focused on oncology. The partnership combines IBA's technology background with Penn Medicine's clinical and research expertise to develop and advance cancer treatment solutions. Details on funding, leadership and the venture's first programs have not yet been made public.
- 5Cairdac Names Former Axonics CEO Raymond Cohen As Chairman▼CAIRDAC Appoints Former Axonics CEO Raymond Cohen As Chairman To Advance Self-Powered Pacemaker Technology
Medical device company Cairdac has appointed Raymond Cohen, the former chief executive of Axonics, as its chairman. Cohen will lead the board as the company develops its self-powered pacemaker technology, which aims to remove the need for battery replacements in patients. The appointment brings experienced leadership to the medtech firm as it advances its device toward broader development.